A
Aralex
Aachen research explorer
Sign in
Menu
Papers
Authors
Topics
Journals
Patents
Institutions
Departments
Sign in
Papers
Authors
Topics
Journals
Patents
Organizations
Institutions
Departments
Company
ROR
OpenAlex
Galapagos (Netherlands)
▲
Sign in to save
159 stored papers ·
Search its papers →
·
Its authors →
Papers
159
Search
Sort
Most cited
Newest
Oldest
Patent citations
Title
Any type
article
review
book-chapter
conference-paper
preprint
dissertation
book
dataset
other
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
Open access
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
2022
Intestinal Research
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
15
citations
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study
2024
Alimentary Pharmacology & Therapeutics
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
14
citations
THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS
2020
Annals of the Rheumatic Diseases
conference-abstract
Medicine
Rheumatoid Arthritis Research and Therapies
Open access
13
citations
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
2022
Journal of Crohn s and Colitis
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
12
citations
Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma
2023
Blood Advances
article
Medicine
Multiple Myeloma Research and Treatments
Open access
12
citations
Impact of filgotinib on pain control in the phase 3 FINCH studies
2024
RMD Open
article
Medicine
Rheumatoid Arthritis Research and Therapies
Open access
12
citations
A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY
2021
Journal of the Canadian Association of Gastroenterology
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
12
citations
Thyroid hormone induces ossification and terminal maturation in a preserved OA cartilage biomimetic model
2024
Arthritis Research & Therapy
article
Medicine
Osteoarthritis Treatment and Mechanisms
Open access
11
citations
Synovial membrane-derived mesenchymal progenitor cells from osteoarthritic joints in dogs possess lower chondrogenic-, and higher osteogenic capacity compared to normal joints
2022
Stem Cell Research & Therapy
article
Medicine
Osteoarthritis Treatment and Mechanisms
Open access
10
citations
POS0092 HERPES ZOSTER IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
2021
Annals of the Rheumatic Diseases
conference-abstract
Medicine
Rheumatoid Arthritis Research and Therapies
10
citations
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
2022
Arthritis Research & Therapy
article
Medicine
Rheumatoid Arthritis Research and Therapies
Open access
10
citations
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial
2023
Journal of Crohn s and Colitis
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
10
citations
ISABELA Studies: Plasma Exposure and Target Engagement Do Not Explain the Lack of Efficacy of Ziritaxestat in Patients with Idiopathic Pulmonary Fibrosis
2023
Clinical Pharmacology & Therapeutics
article
Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Open access
10
citations
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study
2024
United European Gastroenterology Journal
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
9
citations
Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs
2024
Biological Chemistry
article
Medicine
CAR-T cell therapy research
9
citations
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
2025
RMD Open
article
Medicine
Rheumatoid Arthritis Research and Therapies
Open access
8
citations
A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY
2021
Journal of the Canadian Association of Gastroenterology
conference-abstract
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
8
citations
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies
2023
Journal of Crohn s and Colitis
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
7
citations
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study
2024
Inflammatory Bowel Diseases
article
Biochemistry, Genetics and Molecular Biology
Inflammatory Bowel Disease
Open access
7
citations
Cardiac Xenotransplantation: Clinical Impact of Science and Discovery
2022
Circulation
editorial
Medicine
Xenotransplantation and immune response
7
citations
21–40 of 159
← Previous
Page 2 / 8
Next →
Most cited authors
Search all →
▲
Joel R. Sevinsky
Biochemistry, Genetics and Molecular Biology
39.7k
citations
20
h-index
1
Aachen papers
▲
Daniel J. Garry
University of Minnesota
·
Eligo Bioscience (France)
Biochemistry, Genetics and Molecular Biology
16.1k
citations
62
h-index
2
Aachen papers
▲
Christian J. Jacques
Université Laval
Psychology
9.73k
citations
41
h-index
3
Aachen papers
▲
Juozas Nainys
Biochemistry, Genetics and Molecular Biology
5.42k
citations
13
h-index
1
Aachen papers
▲
Mary G. Garry
University of Minnesota
Biochemistry, Genetics and Molecular Biology
4.45k
citations
37
h-index
2
Aachen papers
▲
Bernt van den Blink
Vicore Pharma (Sweden)
Medicine
3.66k
citations
31
h-index
5
Aachen papers
▲
Claire Vennin
Garvan Institute of Medical Research
·
UNSW Sydney
Medicine
3.34k
citations
30
h-index
4
Aachen papers
▲
Cindy J.M. Loomans
Charles River Laboratories (Netherlands)
Medicine
3.26k
citations
17
h-index
2
Aachen papers
▲
Thijs K. Hendrikx
Galapagos (Belgium)
Medicine
2.84k
citations
20
h-index
6
Aachen papers
▲
Joost H. van den Berg
The Netherlands Cancer Institute
·
Galapagos (Netherlands)
Immunology and Microbiology
2.28k
citations
22
h-index
1
Aachen papers
▲
Robert A. Petit
Wyoming State Department of Health
·
Emory University
Biochemistry, Genetics and Molecular Biology
1.89k
citations
20
h-index
1
Aachen papers
▲
Richard A. J. Janssen
Immunology and Microbiology
1.77k
citations
20
h-index
4
Aachen papers
▲
Robin Besuyen
Stedelijk Museum Amsterdam
Medicine
1.56k
citations
16
h-index
37
Aachen papers
▲
Mona Aeysha Khalid
University of Stirling
·
Glasgow Caledonian University
Medicine
1.2k
citations
13
h-index
1
Aachen papers
▲
Margot J. Pont
Galapagos (Netherlands)
Immunology and Microbiology
1.17k
citations
14
h-index
12
Aachen papers
▲
Esmée P. Hoefsmit
The Netherlands Cancer Institute
·
Galapagos (Netherlands)
Medicine
1.11k
citations
14
h-index
4
Aachen papers
▲
Annemarie Lekkerkerker
Genentech
Biochemistry, Genetics and Molecular Biology
1.1k
citations
17
h-index
2
Aachen papers
▲
Claudio Corallo
Medicine
1.04k
citations
17
h-index
1
Aachen papers
▲
Eric Helmer
GlaxoSmithKline (Italy)
·
Galapagos (Netherlands)
Pharmacology, Toxicology and Pharmaceutics
976
citations
11
h-index
1
Aachen papers
▲
Leonardo Chicaybam
Galapagos (Netherlands)
·
Instituto Nacional de Câncer - INCA
Medicine
918
citations
13
h-index
1
Aachen papers